Acquired haemophilia: an overview for clinical practice

CM Kessler, P Knöbl - European Journal of Haematology, 2015 - Wiley Online Library
Acquired haemophilia is a potentially life‐threatening bleeding disorder caused by the
development of autoantibodies against coagulation factors, most commonly against factor …

[HTML][HTML] International recommendations on the diagnosis and treatment of acquired hemophilia A

A Tiede, P Collins, P Knoebl, J Teitel, C Kessler… - …, 2020 - ncbi.nlm.nih.gov
Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

P Collins, F Baudo, A Huth-Kühne, J Ingerslev… - BMC research …, 2010 - Springer
Abstract Background Acquired hemophilia A (AHA) is a rare bleeding disorder caused by an
autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in …

Acquired haemophilia A: a review of what we know

ME Mingot-Castellano… - Journal of Blood …, 2022 - Taylor & Francis
Autoantibodies against plasma coagulation factors could be developed by some individuals
inducing severe and sometimes fatal bleedings. This clinical entity is called acquired …

Acquired hemophilia A: a review of recent data and new therapeutic options

M Franchini, S Vaglio, G Marano, C Mengoli… - …, 2017 - Taylor & Francis
ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …

Acquired hemophilia A

KE Webert - Seminars in thrombosis and hemostasis, 2012 - thieme-connect.com
Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that
act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be …

Acquired hemophilia A

M Pai - Hematology/Oncology Clinics, 2021 - hemonc.theclinics.com
Acquired hemophilia A is a bleeding disorder caused by antibodies to factor VIII (FVIII).
These antibodies—called inhibitors—interfere with normal hemostasis, leading to potentially …

Prevention and management of bleeding episodes in patients with acquired hemophilia A

P Knöbl - Drugs, 2018 - Springer
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies
inhibiting the function of coagulation factor VIII. It is characterized by spontaneous bleeding …

Acquired inhibitors of coagulation factors: part I—acquired hemophilia A

A Coppola, EJ Favaloro, A Tufano… - … in thrombosis and …, 2012 - thieme-connect.com
Acquired hemophilia A (AHA) is a rare, but often severe, bleeding disorder caused by
autoantibodies against clotting factor VIII (FVIII). AHA occurs more frequently in the elderly …

Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies

PA Holme, F Brosstad, GE Tjønnfjord - Haemophilia, 2005 - Wiley Online Library
Acquired haemophilia is a rare, but often severe bleeding disorder caused by
autoantibodies against a coagulation factor, usually factor VIII (FVIII). Between 1997 and …